176 related articles for article (PubMed ID: 23286936)
21. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E
JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642
[TBL] [Abstract][Full Text] [Related]
22. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.
Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC
Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241
[TBL] [Abstract][Full Text] [Related]
23. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.
Cameron R; Davies HR
Cochrane Database Syst Rev; 2008 Apr; (2):CD002312. PubMed ID: 18425881
[TBL] [Abstract][Full Text] [Related]
24. BTS guidelines for the management of pleural infection in children.
Balfour-Lynn IM; Abrahamson E; Cohen G; Hartley J; King S; Parikh D; Spencer D; Thomson AH; Urquhart D;
Thorax; 2005 Feb; 60 Suppl 1(Suppl 1):i1-21. PubMed ID: 15681514
[No Abstract] [Full Text] [Related]
25. Recent Insights into the Management of Pleural Infection.
Hassan M; Patel S; Sadaka AS; Bedawi EO; Corcoran JP; Porcel JM
Int J Gen Med; 2021; 14():3415-3429. PubMed ID: 34290522
[TBL] [Abstract][Full Text] [Related]
26. Concurrent Versus Sequential Intrapleural Instillation of Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection.
Kheir F; Cheng G; Rivera E; Folch A; Folch E; Fernandez-Bussy S; Keyes C; Parikh M; Channick C; Chee A; Majid A
J Bronchology Interv Pulmonol; 2018 Apr; 25(2):125-131. PubMed ID: 29346247
[TBL] [Abstract][Full Text] [Related]
27. ERS/ESTS statement on the management of pleural infection in adults.
Bedawi EO; Ricciardi S; Hassan M; Gooseman MR; Asciak R; Castro-Añón O; Armbruster K; Bonifazi M; Poole S; Harris EK; Elia S; Krenke R; Mariani A; Maskell NA; Polverino E; Porcel JM; Yarmus L; Belcher EP; Opitz I; Rahman NM
Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36229045
[TBL] [Abstract][Full Text] [Related]
28. A systematic review of comorbidities and outcomes of adult patients with pleural infection.
Cargill TN; Hassan M; Corcoran JP; Harriss E; Asciak R; Mercer RM; McCracken DJ; Bedawi EO; Rahman NM
Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31391221
[TBL] [Abstract][Full Text] [Related]
29. Current use of intrapleural tissue plasminogen activator in the treatment of complex pleural processes: a review of the literature and report of 9 cases.
Dulaney CR; Merrill WH; Tesseneer S; Jenkins-Lonidier L; Tribble CG
J Miss State Med Assoc; 2012 Jul; 53(7):216-9. PubMed ID: 23066590
[TBL] [Abstract][Full Text] [Related]
30. The management of pleural space infections.
Chapman SJ; Davies RJ
Respirology; 2004 Mar; 9(1):4-11. PubMed ID: 14982595
[TBL] [Abstract][Full Text] [Related]
31. Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.
Popowicz N; Bintcliffe O; De Fonseka D; Blyth KG; Smith NA; Piccolo F; Martin G; Wong D; Edey A; Maskell N; Lee YCG
Ann Am Thorac Soc; 2017 Jun; 14(6):929-936. PubMed ID: 28324671
[TBL] [Abstract][Full Text] [Related]
32. Intrapleural therapy.
Huggins JT; Doelken P; Sahn SA
Respirology; 2011 Aug; 16(6):891-9. PubMed ID: 21672085
[TBL] [Abstract][Full Text] [Related]
33. Pleural infection and empyema.
Kwon YS
Tuberc Respir Dis (Seoul); 2014 Apr; 76(4):160-2. PubMed ID: 24851128
[TBL] [Abstract][Full Text] [Related]
34. Intrapleural use of tissue plasminogen activator and DNase in pleural infection.
Rahman NM; Maskell NA; West A; Teoh R; Arnold A; Mackinlay C; Peckham D; Davies CW; Ali N; Kinnear W; Bentley A; Kahan BC; Wrightson JM; Davies HE; Hooper CE; Lee YC; Hedley EL; Crosthwaite N; Choo L; Helm EJ; Gleeson FV; Nunn AJ; Davies RJ
N Engl J Med; 2011 Aug; 365(6):518-26. PubMed ID: 21830966
[TBL] [Abstract][Full Text] [Related]
35. Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline.
Colice GL; Curtis A; Deslauriers J; Heffner J; Light R; Littenberg B; Sahn S; Weinstein RA; Yusen RD
Chest; 2000 Oct; 118(4):1158-71. PubMed ID: 11035692
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and management of infectious pleural effusion.
Rahman NM; Chapman SJ; Davies RJ
Treat Respir Med; 2006; 5(5):295-304. PubMed ID: 16928143
[TBL] [Abstract][Full Text] [Related]
37. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z
Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084
[TBL] [Abstract][Full Text] [Related]
38. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
Israel EN; Blackmer AB
Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
[TBL] [Abstract][Full Text] [Related]
39. New strategies to manage complicated pleural effusions.
Safiyeh M; Huang D
Crit Care; 2012 May; 16(3):312. PubMed ID: 22621656
[TBL] [Abstract][Full Text] [Related]
40. Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection. A Single-Center Experience.
Majid A; Kheir F; Folch A; Fernandez-Bussy S; Chatterji S; Maskey A; Fashjian M; Cheng G; Ochoa S; Alape D; Folch E
Ann Am Thorac Soc; 2016 Sep; 13(9):1512-8. PubMed ID: 27333122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
